Indeed, shares of RXRX stock are rocketing more than 10% higher today on some rather intriguing catalysts. Yesterday, the company made a big announcement at the J.P. Morgan Healthcare Conference.

Centaurus Financial Inc. bought a new stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the ...

On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.89 which represents a decrease of $-0.11 or -1.83% from the prior close of $6. The stock opened at $5.97 and ...

On Friday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.7 which represents a decrease of $-0.05 or -0.87% from the prior close of $5.75. The stock opened at $5.78 and ...

Kaustubh Bagalkote Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars Nvidia's purchase of 7.72 million shares of Applied Digital boosted the company's revenue and earnings. Applied Digital ...

Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) increased during the last ... on the decline of Recursion Pharmaceuticals's stock. Short interest data is updated every two weeks.

RECURSION PHARMACEUTICALS INC (RXRX) is a small-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 43% based on the firm’s underlying fundamentals and the ...